Metabolomics of volatile organic compounds in cystic fibrosis patients and controls.
Robroeks CM, van Berkel JJ, Dallinga JW, Jöbsis Q, Zimmermann LJ, Hendriks HJ, Wouters MF, van der Grinten CP, van de Kant KD, van Schooten FJ, Dompeling E.
Robroeks CM, et al. Among authors: van der grinten cp, van schooten fj, van berkel jj, van de kant kd.
Pediatr Res. 2010 Jul;68(1):75-80. doi: 10.1203/PDR.0b013e3181df4ea0.
Pediatr Res. 2010.
PMID: 20351658